Inventor · disambiguated record
Michael Storek
Also filed as: STOREK MICHAEL · STOREK MICHAEL J · STOREK MICHAEL JOHN
7 granted patents·10 pending applications·14 citations·filing 2002–2024
79Inventor score
Top patents by PatentIndex Score
17 records- 0192US11242382B2Humanized anti-complement factor Bb antibodiesGENZYME CORP·Filed 2021·Granted Feb 8, 2022·3 cites·17 claims
- 0292US11053305B2Fusion protein constructs comprising anti-C3d antibody and CR1 polypeptideQ32 BIO INC·Filed 2020·Granted Jul 6, 2021·6 cites·35 claims
- 0388US11053306B2Fusion protein constructs comprising anti-C3d antibody and factor HQ32 BIO INC·Filed 2020·Granted Jul 6, 2021·2 cites·28 claims
- 0477US2024391986A1Humanized anti-complement factor bb antibodies and uses thereofGENZYME CORP·Filed 2024·Application pending·0 cites
- 0574US11999780B2Humanized anti-complement factor Bb antibodies and uses thereofGENZYME CORP·Filed 2021·Granted Jun 4, 2024·0 cites·17 claims
- 0672US8853494B2Stress tolerant transgenic crop plantsBONIN CHRISTOPHER P·Filed 2009·Granted Oct 7, 2014·3 cites·16 claims
- 0768US11879008B2Methods of treating complement mediated diseases with fusion protein constructs comprising anti-C3d antibody and a complement modulatorQ32 BIO INC·Filed 2021·Granted Jan 23, 2024·0 cites·32 claims
- 0862US2024301043A1METHODS OF TREATING COMPLEMENT MEDIATED DISEASES WITH FUSION PROTEIN CONSTRUCTS COMPRISING ANTI-C3d ANTIBODY AND A COMPLEMENT MODULATORQ32 BIO INC·Filed 2023·Application pending·0 cites
- 0962US2024401082A1Treatment of Dry Age-Related Macular DegenerationGENZYME CORP·Filed 2024·Application pending·0 cites
- 1060US2024052062A1Reducing surgery-associated hemolysis in cold agglutinin disease patientsBIOVERATIV USA INC·Filed 2023·Application pending·0 cites
- 1158US2023357433A1Inflammatory cytokines and fatigue in subject with a complement mediated diseaseBIOVERATIV USA INC·Filed 2023·Application pending·0 cites
- 1258US2024025978A1Methods for treating complement-mediated diseasesBIOVERATIV USA INC·Filed 2023·Application pending·0 cites
- 1352US2009325264A1Engineered Delta-15-Fatty Acid DesaturasesSTOREK MICHAEL J·Filed 2009·Application pending·0 cites
- 1450US2015067928A1Stress Tolerant Transgenic Crop PlantsMONSATO TECHNOLOGY LLC·Filed 2014·Application pending·0 cites
- 1548US6987180B2Uridine analogs and techniques for making and usingHARVARD COLLEGE·Filed 2002·Granted Jan 17, 2006·0 cites·6 claims
- 1647US2008014616A1Methods of introducing targeted diversity into nucleic acid moleculesJARRELL KEVIN·Filed 2007·Application pending·0 cites
- 1747US2009081760A1Dmo methods and compositionsMONSANTO TECHNOLOGY LLC·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Storek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →